Fundraising Fox
/Companies
Sign in

Canal Biosciences

Lowell, US · Founded 2024 · Delaware corporation

Find your way into Canal Biosciences

Sign up to see every warm intro you have to Canal Biosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Canal Biosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Canal Biosciences develops DNA library preparation technology for next-generation sequencing, centered on its TrueLink platform and DISTAL-seq products that attach sequencing adaptors to native DNA termini without end repair to preserve template integrity. Its methods target high-precision NGS applications such as liquid biopsy, methylation sequencing, and minimal residual disease detection in cancer.

BiotechDeep TechMedical Devices

Founders & leadership

JPJack Percoskie
Jack PercoskieExecutive
CB
Christopher BenoitNamed on SEC filing
YZYu Zheng
Yu ZhengFounder/co-CEO

Reported raises · per SEC filings

Form D private placements

$2.3M disclosed across 1 round · 2026

▶$2.3MraisedApr 2026 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher BenoitExecutive Officer, Director
  • Jack PercoskieExecutive Officer
  • Yu ZhengExecutive Officer, Director
Offering amount
$3.2M
Amount sold
$2.3M
First sale
Mar 2026
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Portal InnovationsPortal Innovations provides early-stage capital, laboratory space, and operational support to scientists and entrepreneurs building companies in emerging innovation ecosystems. The company connects breakthrough researchers with investors and corporate partners through deep university relationships and in-house scientific expertise.

Companies working in the same space as Canal Biosciences.

Frequently asked questions

What does Canal Biosciences do?
Canal Biosciences develops DNA library preparation technology for next-generation sequencing, centered on its TrueLink platform and DISTAL-seq products that attach sequencing adaptors to native DNA termini without end repair to preserve template integrity. Its methods target high-precision NGS applications such as liquid biopsy, methylation sequencing, and minimal residual disease detection in cancer.
How much funding has Canal Biosciences raised?
Canal Biosciences has disclosed $2.3M raised across 1 round.
Where is Canal Biosciences headquartered?
Canal Biosciences is headquartered in Lowell, US.